Search

Author/Creator Delahaye, Tim

1. An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma. Issue 6 (27th October 2021)

Authors:
De Meulenaere, Astrid; Vermassen, Tijl; Creytens, David; De Keukeleire, Stijn; Delahaye, Tim; Deron, Philippe; Duprez, Fréderic; Fung, Samson; Pauwels, Patrick; Ferdinande, Liesbeth; Rottey, Sylvie
Journal:
Clinical and translational science
Issue:
Volume 14:Issue 6(2021)
Page Start:
2300
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma. Issue 5 (2nd November 2021)

Authors:
Leupin, Nicolas; Zinzani, Pier Luigi; Morschhauser, Franck; Dalle, Stéphane; Maerevoet, Marie; Michot, Jean‐Marie; Ribrag, Vincent; Offner, Fritz; Beylot‐Barry, Marie; Moins‐Teisserenc, Hélène; Zwaenepoel, Karen; de Winne, Koen; Battistella, Maxime; Hultberg, Anna; Gandini, Domenica; Moshir, Maha...
Journal:
Cancer
Issue:
Volume 128:Issue 5(2022)
Page Start:
1004
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search